Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, Dominic M., Klyubin, Igor, Fadeeva, Julia V., Cullen, William K., Anwyl, Roger, Wolfe, Michael S., Rowan, Michael J., Selkoe, Dennis J.·2002·Nature
DOI 10.1038/416535a

Cited by (1,067)

Items 501–600 of 1,067

  1. Microglial activation facilitates Aβ plaque removal following intracranial anti-Aβ antibody administration
    Wilcock, Donna M, Munireddy, Sanjay K, Rosenthal, Arnon, Ugen, Kenneth E, Gordon, Marcia N, Morgan, Dave · 2004 · Neurobiology of Disease
  2. Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers
    Luibl, V. · 2006 · Journal of Clinical Investigation
  3. Neurotoxic protein oligomers — what you see is not always what you get
    Bitan, Gal, Fradinger, Erica A, Spring, Sean M, Teplow, David B · 2005 · Amyloid
  4. Emerging roles of pathogens in Alzheimer disease
    Judith Miklossy · 2011 · Expert Reviews in Molecular Medicine
  5. Amyloid-β and Tau at the Crossroads of Alzheimer’s Disease
    Gilbert Gallardo, David M. Holtzman · 2019 · Advances in experimental medicine and biology
  6. Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies
    Sara Snogerup Linse, Tom Scheidt, Katja Bernfur, Michele Vendruscolo, Christopher Martin Dobson, Samuel I. A. Cohen, Eimantas Šileikis, Martin Lundqvist, Fang Qian, Tiernan T. O’Malley et al. · 2020 · Nature Structural & Molecular Biology
  7. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease
    Chuang Guo, Tao Wang, Wei Hui Zheng, Zhongyan Shan, Weiping Teng, Zhan‐You Wang · 2012 · Neurobiology of Aging
  8. Metabotropic NMDA receptor function is required for β-amyloid–induced synaptic depression
    Helmut W. H. G. Kessels, Sadegh Nabavi, Roberto Malinow · 2013 · Proceedings of the National Academy of Sciences
  9. Distinct Effects of Zn2+, Cu2+, Fe3+, and Al3+ on Amyloid-β Stability, Oligomerization, and Aggregation
    Wei-Ting Chen, Yi‐Hung Liao, Hui-Ming Yu, Irene Han-Juo Cheng, Yun‐Ru Chen · 2011 · Journal of Biological Chemistry
  10. β-Amyloid impairs axonal BDNF retrograde trafficking
    Wayne W. Poon, Mathew M. Blurton-Jones, Christina H. Tu, Leila M. Feinberg, Meredith A. Chabrier, Joe W. Harris, Noo Li Jeon, Carl W. Cotman · 2009 · Neurobiology of Aging
  11. Substoichiometric Levels of Cu2+ Ions Accelerate the Kinetics of Fiber Formation and Promote Cell Toxicity of Amyloid-β from Alzheimer Disease
    Sarell, Claire J., Wilkinson, Shane R., Viles, John H. · 2010 · Journal of Biological Chemistry
  12. Detection of Misfolded Aβ Oligomers for Sensitive Biochemical Diagnosis of Alzheimer’s Disease
    Natalia Salvadores, Mohammad Shahnawaz, Elio Angelo Scarpini, Fabrizio Tagliavini, Claudio A. Soto · 2014 · Cell Reports
  13. Soluble Amyloid β-Oligomers Affect Dielectric Membrane Properties by Bilayer Insertion and Domain Formation: Implications for Cell Toxicity
    Gintaras Valinčius, Frank Heinrich, Rima Budvytytė, David J. Vanderah, Duncan J. McGillivray, Yuri Sokolov, James E. Hall, Mathias Lösche · 2008 · Biophysical Journal
  14. Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease
    H. Rheinallt Parri, Caterina M. Hernandez, Kelly T. Dineley · 2011 · Biochemical Pharmacology
  15. Adverse Stress, Hippocampal Networks, and Alzheimer’s Disease
    Sarah M. Rothman, Mark P. Mattson · 2009 · NeuroMolecular Medicine
  16. The β-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism
    Petratos, Steven, Li, Qiao-Xin, George, Amee J., Hou, Xu, Kerr, Megan L., Unabia, Sharon E., Hatzinisiriou, Irene, Maksel, Danuta, Aguilar, Marie-Isabel, Small, David H. · 2008 · Brain
  17. Protein aggregation in disease: a role for folding intermediates forming specific multimeric interactions
    Arthur L. Horwich · 2002 · Journal of Clinical Investigation
  18. Metabolite-initiated protein misfolding may trigger Alzheimer's disease
    Qinghai Zhang, Evan T. Powers, Jorge J. Nieva, Mary E. Huff, Maria A. Dendle, Jan Bieschke, Charles G. Glabe, Albert Eschenmoser, Paul Wentworth, Richard Alan Lerner et al. · 2004 · Proceedings of the National Academy of Sciences
  19. Nucleation-Dependent Polymerization Is an Essential Component of Amyloid-Mediated Neuronal Cell Death
    Wogulis, Mark, Wright, Sarah, Cunningham, Damian, Chilcote, Tamie, Powell, Kyle, Rydel, Russell E. · 2005 · The Journal of Neuroscience
  20. A label-free electrical impedimetric biosensor for the specific detection of Alzheimer's amyloid-beta oligomers
    Jo V. Rushworth, Asif Ahmed, Heledd Jarosz-Griffiths, Niall M. Pollock, Nigel M. Hooper, Paul A. Millner · 2013 · Biosensors and Bioelectronics
  21. Mitochondrial Dysfunction: The First Domino in Brain Aging and Alzheimer's Disease?
    Kristina Leuner, Susanne Hauptmann, Reham Mahmoud Abdel-Kader, Isabel Scherping, Uta Keil, Joanna Benigna Strosznajder, Anne Eckert, Walter E. Müller · 2007 · Antioxidants and Redox Signaling
  22. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Aβ oligomerization
    Fernanda G. De Felice, Marcelo N. N. Vieira, Leonardo Martins Saraiva, José Daniel Figueroa‐Villar, José Garcia-Abreu, Roy Liu, Lei Chang, W L Klein, Sergio Teixeira Ferreira · 2004 · The FASEB Journal
  23. Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates
    T. Klingstedt, A. Åslund, Rozalyn Simon, Leif B. G. Johansson, J. Mason, Sofie Nyström, P. Hammarström, K. P. Nilsson · 2011 · Organic and biomolecular chemistry
  24. Neurotrophins, synaptic plasticity and dementia
    Ottavio Arancio, Moses V. Chao · 2007 · Current Opinion in Neurobiology
  25. CSF Biomarkers for Alzheimer's Disease Diagnosis
    Anoop Arunagiri, Pradeep Kumar Singh, Reeba Susan Jacob, Samir Kumar Maji · 2010 · International Journal of Alzheimer s Disease
  26. β-Amyloid-Mediated Inhibition of NMDA Receptor-Dependent Long-Term Potentiation Induction Involves Activation of Microglia and Stimulation of Inducible Nitric Oxide Synthase and Superoxide
    Qinwen Wang, Michael J. Rowan, Roger Anwyl · 2004 · Journal of Neuroscience
  27. Alzheimer’s Disease, Oligomers, and Inflammation
    Gianluigi Forloni, Claudia Balducci · 2018 · Journal of Alzheimer s Disease
  28. Molecular Dynamics Simulation of Amyloid β Dimer Formation
    Brigita Urbanc, Luis Cruz, Feng Ding, Deanne W. Sammond, Sagar D. Khare, Sergey V. Buldyrev, Eugene Stanley, Nikolay V. Dokholyan · 2004 · Biophysical Journal
  29. Intranasal H102 Peptide-Loaded Liposomes for Brain Delivery to Treat Alzheimer’s Disease
    Xiaoyao Zheng, Xiayan Shao, Chi Zhang, Yuanzhen Tan, Qingfeng Liu, Wan Xu, Qizhi Zhang, Shumei Xu, Xinguo Jiang · 2015 · Pharmaceutical Research
  30. β-Amyloid Is Different in Normal Aging and in Alzheimer Disease
    Alessandra Piccini, Claudio Russo, Alessandra Gliozzi, Annalisa Relini, Antonella Vitali, Roberta Borghi, Luca Giliberto, Andrea Armirotti, Cristina D’Arrigo, Angela Bachi et al. · 2005 · Journal of Biological Chemistry
  31. The duality of amyloid-β: its role in normal and Alzheimer’s disease states
    Ali Azargoonjahromi · 2024 · Molecular Brain
  32. Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Aβ42 peptide
    Woojin Kim, Michael H. Hecht · 2006 · Proceedings of the National Academy of Sciences
  33. Structure and functions of the human amyloid precursor protein: The whole is more than the sum of its parts
    Matthias Gralle, Sergio Teixeira Ferreira · 2007 · Progress in Neurobiology
  34. Ferulic Acid Is a Nutraceutical β-Secretase Modulator That Improves Behavioral Impairment and Alzheimer-like Pathology in Transgenic Mice
    Takashi Mori, Naoki Koyama, Marie‐Victoire Guillot‐Sestier, Jun Tan, Terrence Town · 2013 · PLoS ONE
  35. Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain
    Chuang Guo, Pu Wang, Manli Zhong, Tao Wang, Xueshi Huang, Jiayi Li, Zhan‐You Wang · 2012 · Neurochemistry International
  36. A three-step model for the synaptic recruitment of AMPA receptors
    Opazo, Patricio, Choquet, Daniel · 2011 · Molecular and Cellular Neuroscience
  37. Alzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms
    Rommy von Bernhardi M., Jaime L. Eugenín · 2011 · Antioxidants and Redox Signaling
  38. Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics
    Goure, William F, Krafft, Grant A, Jerecic, Jasna, Hefti, Franz · 2014 · Alzheimer's Research & Therapy
  39. Neurotoxic, Redox-competent Alzheimer's β-Amyloid Is Released from Lipid Membrane by Methionine Oxidation
    Kevin Jeffrey Barnham, Giuseppe D. Ciccotosto, Anna K. Tickler, Feda E. A. Ali, Danielle G. Smith, Nicholas A. Williamson, Yuen-Han Lam, Darryl Carrington, Deborah J. Tew, Gulcan Kocak et al. · 2003 · Journal of Biological Chemistry
  40. Chemical and Biological Approaches for Adapting Proteostasis to Ameliorate Protein Misfolding and Aggregation Diseases-Progress and Prognosis
    Susan Lindquist, Jeffery W. Kelly · 2011 · Cold Spring Harbor Perspectives in Biology
  41. Methylene Blue Inhibits Amyloid Aβ Oligomerization by Promoting Fibrillization
    Necula, Mihaela, Breydo, Leonid, Milton, Saskia, Kayed, Rakez, van der Veer, Wytze E., Tone, Paul, Glabe, Charles G. · 2007 · Biochemistry
  42. Nature of the Amyloid-β Monomer and the Monomer-Oligomer Equilibrium
    Suman Nag, Bidyut Sarkar, Arkarup Bandyopadhyay, Bankanidhi Sahoo, Varun K. A. Sreenivasan, Mamata H. Kombrabail, Muralidharan Chandrakesan, Sudipta Maiti · 2011 · Journal of Biological Chemistry
  43. Amyloidogenesis of Natively Unfolded Proteins
    Vladimir Nikolaevich Uversky · 2008 · Current Alzheimer Research
  44. The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice
    Paul H. Wen, Patrick R. Hof, Xiaoping Chen, Karen Gluck, Gregory Austin, Steven G. Younkin, Linda H. Younkin, Rita DeGasperi, Miguel A. Gama Sosa, Nikolaos K. R K Robakis et al. · 2004 · Experimental Neurology
  45. Therapeutic strategies for Alzheimer's disease
    Michael S. Wolfe · 2002 · Nature Reviews Drug Discovery
  46. Amyloid-β and τ serve antioxidant functions in the aging and Alzheimer brain
    Mark A. Smith, Gemma Casadesús, James A. Joseph, George L. Perry · 2002 · Free Radical Biology and Medicine
  47. Inhibition of Calcineurin-mediated Endocytosis and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Prevents Amyloid β Oligomer-induced Synaptic Disruption
    Zhao, Wei-Qin, Santini, Francesca, Breese, Robert, Ross, Dave, Zhang, Xiaohua Douglas, Stone, David J., Ferrer, Marc, Townsend, Matthew, Wolfe, Abigail L., Seager, Matthew A. et al. · 2010 · Journal of Biological Chemistry
  48. Calcium/calmodulin-dependent kinase II and Alzheimer’s disease
    Ghosh, Anshua, Giese, Karl Peter · 2015 · Molecular Brain
  49. Angiotensin-Converting Enzyme Converts Amyloid β-Protein 1–42 (Aβ1–42) to Aβ1–40, and Its Inhibition Enhances Brain Aβ Deposition
    Kun Zou, H. Yamaguchi, H. Akatsu, Takaaki Sakamoto, Mihee Ko, K. Mizoguchi, J. Gong, Wenxin Yu, Takayuki Yamamoto, K. Kosaka et al. · 2007 · Journal of Neuroscience
  50. In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid β-peptide of APP
    David Allan Butterfield, Verónica Galván, Miranda L. Bader Lange, Huidong Tang, Renã A. S. Robinson, Patricia R. Spilman, Joanna Fombonne, Olivia F. Gorostiza, Junli Zhang, Rukhsana Sultana A et al. · 2009 · Free Radical Biology and Medicine
  51. S100 Proteins in Alzheimer’s Disease
    Cristóvão, Joana S., Gomes, Cláudio M. · 2019 · Frontiers in Neuroscience
  52. HIV-1 Tat inhibits neprilysin and elevates amyloid β
    Hans C Rempel, Lynn Pulliam · 2005 · AIDS
  53. Amyloid Peptide Channels
    Bruce L. Kagan, Rustam Azimov, R. Azimova · 2004 · The Journal of Membrane Biology
  54. Synapse-Associated Protein-97 Mediates α-Secretase ADAM10 Trafficking and Promotes Its Activity
    Elena E. Marcello, Fabrizio Gardoni, Daniela Mauceri, Stefano Romorini, Andreas Jeromin, Roberta Epis, Barbara Borroni, Flaminio Cattabeni, Carlo Sala, Alessandro Padovani et al. · 2007 · Journal of Neuroscience
  55. Models of β-Amyloid Ion Channels in the Membrane Suggest That Channel Formation in the Bilayer Is a Dynamic Process
    Hyunbum Jang, Jie Zheng, Ruth Nussinov · 2007 · Biophysical Journal
  56. Crucial role of nonspecific interactions in amyloid nucleation
    Anđela Šarić, Yassmine Chebaro, Tuomas P. J. Knowles, Daan Frenkel · 2014 · Proceedings of the National Academy of Sciences
  57. Exosomes neutralize synaptic-plasticity-disrupting activity of Aβ assemblies in vivo
    Kyongman An, Igor V. Klyubin, Youngkyu Kim, Jung Hoon Jung, Alexandra J. Mably, Seán O’Dowd, Timothy Lynch, Daniel Kanmert, Cynthia Ann Lemere, Gina M. Finan et al. · 2013 · Molecular Brain
  58. A Comparison of Three Fluorophores for the Detection of Amyloid Fibers and Prefibrillar Oligomeric Assemblies. ThT (Thioflavin T); ANS (1-Anilinonaphthalene-8-sulfonic Acid); and bisANS (4,4'-Dianilino-1,1'-binaphthyl-5,5'-disulfonic Acid).
    Nadine D. Younan, J. H. Viles · 2015 · Biochemistry
  59. A strategy for designing inhibitors of α ‐synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders
    Omar M. A. El‐Agnaf, Katerina E. Paleologou, Brett Greer, Abdulmawala M. Abogrein, Jenny E. King, Sultan A. Salem, Nigel J. Fullwood, Fiona E. Benson, Rebecca Hewitt, Kirstie J. Ford et al. · 2004 · The FASEB Journal
  60. Selective Translational Control of the Alzheimer Amyloid Precursor Protein Transcript by Iron Regulatory Protein-1
    Hyun-Hee Cho, Catherine M. Cahill, Charles R. Vanderburg, Clemens R. Scherzer, Bin Wang, Xudong Huang, Jack T. Rogers · 2010 · Journal of Biological Chemistry
  61. The Oxidative Stress Metabolite 4-Hydroxynonenal Promotes Alzheimer Protofibril Formation
    Sarah J. Siegel, Jan Bieschke, Evan T. Powers, Jeffery W. Kelly · 2007 · Biochemistry
  62. Huntingtin Bodies Sequester Vesicle-Associated Proteins by a Polyproline-Dependent Interaction
    Zheng‐Hong Qin, Yumei Wang, Ellen Sapp, Benjamin Cuiffo, Erich E. Wanker, Michael R. Hayden, Kimberly B. Kegel, Neil Aronin M. D, Marian DiFiglia · 2004 · Journal of Neuroscience
  63. Role of the ubiquitin proteasome system in Alzheimer's disease
    Sudarshan C. Upadhya, Ashok N. Hegde · 2007 · BMC Biochemistry
  64. Melatonin treatment restores mitochondrial function in Alzheimer’s mice: a mitochondrial protective role of melatonin membrane receptor signaling
    Natasa Dragicevic, Neil Copes, Gina O’Neal-Moffitt, Jingji Jin, Robert W. Buzzeo, Maggie Mamcarz, Jun Tan, Chuanhai Cao, James Olcese, Gary W. Arendash et al. · 2011 · Journal of Pineal Research
  65. Protein aggregation in disease: a role for folding intermediates forming specific multimeric interactions
    Arthur L. Horwich · 2002 · Journal of Clinical Investigation
  66. Neuronal Cell Death in Alzheimers Disease and a Neuroprotective Factor, Humanin
    Niikura, Takako, Tajima, Hirohisa, Kita, Yoshiko · 2006 · Current Neuropharmacology
  67. Neural compensation in older people with brain amyloid-β deposition
    Jeremy A. Elman, Hwamee Oh, Cindee M. Madison, Suzanne L. Baker, Jacob W. Vogel, Shawn M. Marks, Sam Crowley, James P. O’Neil, William J. Jagust · 2014 · Nature Neuroscience
  68. Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer’s disease mouse model
    Yongfang Zhang, Pradeep K. Kurup, Jian Xu, Nikisha Carty, Stephanie M. Fernandez, Haakon B. Nygaard, Christopher Pittenger, Paul Greengard, Stephen M. Strittmatter, Angus Clark Nairn et al. · 2010 · Proceedings of the National Academy of Sciences
  69. Direct characterization of amyloidogenic oligomers by single-molecule fluorescence
    Ángel Orte, Neil R. Birkett, Richard W. Clarke, Glyn L. Devlin, Christopher Martin Dobson, David Klenerman · 2008 · Proceedings of the National Academy of Sciences
  70. Memantine Improves Spatial Learning in a Transgenic Mouse Model of Alzheimer’s Disease
    Rimante Minkeviciene, Pradeep Banerjee, Heikki Tanila · 2004 · Journal of Pharmacology and Experimental Therapeutics
  71. Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer’s disease-like pathology
    Nuriel, Tal, Angulo, Sergio L., Khan, Usman, Ashok, Archana, Chen, Qiuying, Figueroa, Helen Y., Emrani, Sheina, Liu, Li, Herman, Mathieu, Barrett, Geoffrey et al. · 2017 · Nature Communications
  72. Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity
    Massimo Stefani · 2010 · FEBS Journal
  73. A central role for dityrosine crosslinking of Amyloid-β in Alzheimer’s disease
    Youssra K. Al‐Hilaly, Thomas L. Williams, Maris Stewart-Parker, Lenzie K. Ford, Eldhose Skaria, Michael Cole, William Grant Bucher, Kyle L. Morris, Alaa Abdul Sada, Julian R. Thorpe et al. · 2013 · Acta Neuropathologica Communications
  74. Oligomeric Amyloid Decreases Basal Levels of Brain-Derived Neurotrophic factor (BDNF) mRNA via Specific Downregulation of BDNF Transcripts IV and V in Differentiated Human Neuroblastoma Cells
    Diego J. Garzon, Margaret L. Fahnestock · 2007 · Journal of Neuroscience
  75. Oligomeric amyloid-β peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism
    Berman, Diego E, Dall'Armi, Claudia, Voronov, Sergey V, McIntire, Laura Beth J, Zhang, Hong, Moore, Ann Z, Staniszewski, Agniezka, Arancio, Ottavio, Kim, Tae-Wan, Di Paolo, Gilbert · 2008 · Nature Neuroscience
  76. Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer’s disease
    Amandine Grimm, Kristina Friedland, Anne Eckert · 2015 · Biogerontology
  77. Amyloid Beta: Multiple Mechanisms of Toxicity and Only Some Protective Effects?
    Paul Carrillo‐Mora, Rogelio Luna, Laura Colín-Barenque · 2014 · Oxidative Medicine and Cellular Longevity
  78. Pathological Interface Between Oligomeric Alpha-Synuclein and Tau in Synucleinopathies
    Urmi Sengupta, Marcos Jair Guerrero‐Munoz, Diana Laura Castillo‐Carranza, Cristian A. Lasagna‐Reeves, Julia E. Gerson, Adriana A. Paulucci-Holthauzen, Shashirekha Krishnamurthy, Malika Farhed, George R. Jackson, Rakez Kayed · 2015 · Biological Psychiatry
  79. Neprilysin-sensitive Synapse-associated Amyloid-β Peptide Oligomers Impair Neuronal Plasticity and Cognitive Function
    Shu-Ming Huang, Akihiro Mouri, Hideko Kokubo, Ryuichi Nakajima, Takahiro Suemoto, Makoto Higuchi, Matthias Staufenbiel, Yukihiro Noda, Haruyasu Yamaguchi, Toshitaka Nabeshima et al. · 2006 · Journal of Biological Chemistry
  80. ‘Unfolding’ pathways in neurodegenerative disease
    Mark S. Forman, Virginia M.‐Y. Lee, John Q. Trojanowski · 2003 · Trends in Neurosciences
  81. Fluid Biomarkers for Synaptic Dysfunction and Loss
    Camporesi, Elena, Nilsson, Johanna, Brinkmalm, Ann, Becker, Bruno, Ashton, Nicholas J, Blennow, Kaj, Zetterberg, Henrik · 2020 · Biomarker Insights
  82. Peptidyl-prolyl cis–trans isomerase Pin1 in ageing, cancer and Alzheimer disease
    Tae Ho Lee, Lucia Pastorino, Kun Ping Lu · 2011 · Expert Reviews in Molecular Medicine
  83. Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence?
    Sakeneh Zraika, Rebecca L. Hull, C. Bruce Verchere, Anne Clark, Kathryn J. Potter, Paul E. Fraser, Daniel P. Raleigh, Steven E. Kahn · 2010 · Diabetologia
  84. Phospholipase D2 Ablation Ameliorates Alzheimer's Disease-Linked Synaptic Dysfunction and Cognitive Deficits
    Tiago Gil Oliveira, Robin Chan, Huasong Tian, Mikaël Laredo, Guanghou Shui, Agnieszka Staniszewski, Hong Zhang, Lili Wang, Tae‐Wan Kim, Karen Duff et al. · 2010 · Journal of Neuroscience
  85. Interaction of the Molecular Chaperone DNAJB6 with Growing Amyloid-beta 42 (Aβ42) Aggregates Leads to Sub-stoichiometric Inhibition of Amyloid Formation
    Cecilia Månsson, Paolo Arosio, Rasha Mohamed Hussein, Harm H. Kampinga, Reem M. Hashem, Wilbert C. Boelens, Christopher Martin Dobson, Tuomas P. J. Knowles, Sara Snogerup Linse, Cecilia Sundby Emanuelsson · 2014 · Journal of Biological Chemistry
  86. The neuropathogenic contributions of lysosomal dysfunction
    Ben A. Bahr, Jennifer Bendiske · 2002 · Journal of Neurochemistry
  87. RAGE and Alzheimer's Disease: A Progression Factor for Amyloid-β-Induced Cellular Perturbation?
    Shi Du Yan, Angelika Bierhaus, Peter P. Nawroth, David M. Stern · 2009 · Journal of Alzheimer s Disease
  88. Tannic Acid Is a Natural β-Secretase Inhibitor That Prevents Cognitive Impairment and Mitigates Alzheimer-like Pathology in Transgenic Mice
    Takashi Mori, Kavon P. Rezai-Zadeh, Naoki Koyama, Gary W. Arendash, Haruyasu Yamaguchi, Nobuto Kakuda, Yuko Horikoshi‐Sakuraba, Jun Tan, Terrence Town · 2012 · Journal of Biological Chemistry
  89. Size-dependent neurotoxicity of β-amyloid oligomers
    Paulius Čižas, Rima Budvytytė, Ramunė Morkūnienė, Radu Moldovan, Matteo Broccio, Mathias Lösche, Gediminas Niaura, Gintaras Valinčius, Vilmantė Borutaitė · 2010 · Archives of Biochemistry and Biophysics
  90. β-Amyloid Impairs AMPA Receptor Trafficking and Function by Reducing Ca2+/Calmodulin-dependent Protein Kinase II Synaptic Distribution
    Zhenglin Gu, Wenhua Liu, Zhen Yan · 2009 · Journal of Biological Chemistry
  91. Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer’s Disease?
    Antoine Louveau, Sandro Dá Mesquita, Jonathan Kipnis · 2016 · Neuron
  92. Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn‐mediated local protein translation
    Chuanzhou Li, Jürgen Götz · 2017 · The EMBO Journal
  93. Hypotrichosis simplex of the scalp is associated with nonsense mutations in CDSN encoding corneodesmosin
    Etgar Levy‐Nissenbaum, Regina Christine Betz, Moshe Frydman, Michel Simon, Hadas Lahat, Tengiz Bakhan, Boleslaw Goldman, Anette Bygum, Monika Pierick, Axel M. Hillmer et al. · 2003 · Nature Genetics
  94. Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration
    Sarah J Shoesmith Berke, Henry Lauris Paulson · 2003 · Current Opinion in Genetics & Development
  95. β-Amyloid Immunotherapy Prevents Synaptic Degeneration in a Mouse Model of Alzheimer's Disease
    Buttini, Manuel, Masliah, Eliezer, Barbour, Robin, Grajeda, Henry, Motter, Ruth, Johnson-Wood, Kelly, Khan, Karen, Seubert, Peter, Freedman, Stephen, Schenk, Dale et al. · 2005 · The Journal of Neuroscience
  96. Kinetic control of dimer structure formation in amyloid fibrillogenesis
    Wonmuk Hwang, Shuguang Zhang, Roger Dale Kamm, Martin Karplus · 2004 · Proceedings of the National Academy of Sciences
  97. Structural features and cytotoxicity of amyloid oligomers: Implications in Alzheimer's disease and other diseases with amyloid deposits
    Massimo Stefani · 2012 · Progress in Neurobiology
  98. Synaptic Depression and Aberrant Excitatory Network Activity in Alzheimer’s Disease: Two Faces of the Same Coin?
    Jorge J. Palop, Lennart Mucke · 2009 · NeuroMolecular Medicine
  99. Environmental Novelty Activates β2-Adrenergic Signaling to Prevent the Impairment of Hippocampal LTP by Aβ Oligomers
    Shaomin Li, Ming Jin, Dainan Zhang, Ting Yang, Thomas Koeglsperger, Hongjun Fu, Dennis J. Selkoe · 2013 · Neuron
  100. Differential Regulation of Amyloid-β Endocytic Trafficking and Lysosomal Degradation by Apolipoprotein E Isoforms
    Jie Li, Takahisa Kanekiyo, Mitsuru Shinohara, Yun‐wu Zhang, Mary Jo LaDu, Huaxi Xu, Guojun Bu · 2012 · Journal of Biological Chemistry